BSI (British Standards Institution) has announced that it has certified its first Active Implantable Medical Device (AIMD) products, Abbott’s neuromodulation clinician programmer app and its patient controller app for use on compatible personal Apple smartphone devices, to the Medical Devices Regulation (MDR) (EU 2017/745) via its Notified Body in The Netherlands (2797).
All Active Implantable Medical Devices and their accessories are classified as Class III and subject to the most rigorous regulatory controls. The BSI certificate is the first to meet the EU Technical Documentation Assessment Certificate, Regulation (EU) 2017/745, Annex IX, Chapter II.
Abbott’s Clinician Programmer app certified
Abbott’s Clinician Programmer app enables clinicians to create customised therapy for neurological conditions, including chronic pain or movement disorders, and the Patient Controller app helps patients manage their prescribed stimulation programs.
This certification allows Abbott’s portfolio of neuromodulation devices, including Infinity DBS System for patients with Parkinson's disease or disabling tremor, as well as Proclaim XR SCS System and Proclaim DRG Neurostimulation System for patients living with chronic pain, to be controlled from a tablet or mobile phone.
Integration across Abbott neuromodulation technologies
The assessment included an initial MDR application, audit, software applications, patient kits"
This integration across all Abbott neuromodulation technologies will allow patients to more seamlessly interact with their physicians, thereby enabling enhanced communication and better management.
Paul Risborough, the Global Head of AIMD at BSI, said “The assessment included an initial MDR application, audit, software applications, patient kits, and software enhancements. Due to the nature of the product, cyber security controls featured heavily in the review. I am proud of the team of 14 people, who contributed internally to the review. The team really pulled together to make this happen.”
BSI certification of Active Implantable Medical Device products
Gary Slack, the Senior Vice-President of the Notified Body at BSI, said “Meeting the requirements for these high-risk devices has been a steep learning curve, especially with many new review forms and many new requirements. As a notified body, we have learnt significant amounts during our early reviews. Our teams are working and learning in parallel to share best practice.”
Gary Slack adds, “This certificate required our dedicated clinical assessors and is the first issue of a clinical evaluation assessment report (CEAR). We are developing our systems and processes to improve our service levels to clients for these rigorous regulatory requirements.”
- Network / IP
- Electronic security systems
- Office security systems
- Office security
- Application security
- Physical security
- Hospital security
- Commercial security
- Perimeter security
- Healthcare security
- Private sector security
- Public sector security
- Security management
- Security policy
- Security devices
- Security installation
- Security tagging
- Security access systems
- Asset tracking
- Electronic access control
- Building security
- Facility security
- Public security
- Door access control
- Security service
- Physical Security Information Management (PSIM)
- IP security solutions
- Security communication
- Perimeter protection
- Research & Testing
- Cyber security
- Internet of Things (IoT)
- Corporate Security
- Data Security
- Incident Management
- Security Assessments
- Cloud security
- Artificial intelligence (AI)
- Mobile access
- Machine Learning
- Touchless Security
